Piso P, Bektas H, Werner U, Becker T, Aselmann H, Schlitt H J, Klempnauer J
Klinik für Viszeral- und Transplantationschirurgie, Zentrum Chirurgie, Medizinischen Hochschule Hannover, Germany.
Zentralbl Chir. 2002 Apr;127(4):270-4. doi: 10.1055/s-2002-31553.
While gastric cancer shows an increased incidence in elderly patients, the rate of younger patients affected by this disease represents up to 15 %. Younger patients are frequently diagnosed with advanced tumor stages with a poor prognosis although literature data on this issue are controversial.
643 patients with primary gastric carcinoma were operated in our institution between March 1986 and December 2000. No neoadjuvant treatment was administered in these patients. We analysed the data of these patients retrospectively. A comparison of the results between patients younger than 40 years (n = 38, median age 37 years) and older than 70 years (n = 182, median age 75 years) was performed.
The radical (R0-) resectability rate was rather high for both, younger (78.9 %) and elderly (76.9 %) patients. Postoperative morbidity was higher in elderly than in younger patients (32.9 % vs. 23.2 %; p < 0.05), as well as the postoperative mortality (7.7 % vs. 2.6 %; p < 0.05). Both younger and elderly patients showed advanced (II to IV) tumor stages (76.3 % vs. 73.3 %, n. s.). There was a significant difference between the rate of diffuse carcinomas in young and elderly patients (63.2 % vs. 22.5 %). The 5-years survival rate following R0-resection was significantly higher for younger patients (54.2 % vs. 32.9 %; p = 0.01), differences occurred only after the second postoperative year.
The resectability of gastric carcinoma is not related to the patients age. Due to comorbidity, postoperative morbidity may be increased in elderly patients. Although both younger and elderly patients show advanced tumor stages, diffuse carcinomas are more frequent in younger patients. The short-term prognosis is similar for both age groups, long-term results are better for younger patients. The different life expectancy should be considered when interpreting these results.
虽然老年患者胃癌发病率有所上升,但受该疾病影响的年轻患者比例高达15%。尽管关于这一问题的文献数据存在争议,但年轻患者经常被诊断为肿瘤晚期,预后较差。
1986年3月至2000年12月期间,我院对643例原发性胃癌患者进行了手术。这些患者均未接受新辅助治疗。我们对这些患者的数据进行了回顾性分析。对年龄小于40岁(n = 38,中位年龄37岁)和年龄大于70岁(n = 182,中位年龄75岁)的患者结果进行了比较。
年轻患者(78.9%)和老年患者(76.9%)的根治性(R0 -)切除率都相当高。老年患者术后发病率高于年轻患者(32.9%对23.2%;p < 0.05),术后死亡率也是如此(7.7%对2.6%;p < 0.05)。年轻患者和老年患者均表现为晚期(II至IV期)肿瘤(76.3%对73.3%,无显著差异)。年轻患者和老年患者弥漫性癌的发生率存在显著差异(63.2%对22.5%)。R0切除术后年轻患者的5年生存率显著更高(54.2%对32.9%;p = 0.01),差异仅在术后第二年之后出现。
胃癌的可切除性与患者年龄无关。由于合并症,老年患者术后发病率可能会增加。虽然年轻患者和老年患者均表现为晚期肿瘤,但年轻患者中弥漫性癌更为常见。两个年龄组的短期预后相似,年轻患者的长期结果更好。在解释这些结果时应考虑不同的预期寿命。